Latest News
Conference Coverage
Weaknesses exposed in valsartan recall
PHILADELPHIA – A population study in Canada exposed incomplete adherence after the valsartan recall of July 2018.
Feature
Feds propose new price transparency rules in health care
The goal of the proposal is to give consumers enough information to shop around for medical services.
News from the FDA/CDC
FDA panel supports Vascepa expanded indication for CVD reduction
Icosapent ethyl (Vascepa), purified eicosapentaenoic acid, got unanimous support from an FDA panel for a new indication of reducing CVD events.
Feature
Open enrollment 2020: HealthCare.gov activity down from last year
Nevada opened its own exchange this year and moved off the federal system.
Latest News
FDA panel rejects new empagliflozin indication for type 1 diabetes
Panelists voted 14-2 against the application and criticized the limited data supporting the application.
From the Journals
Bempedoic acid cuts LDL by 15% in patients already on maximal treatment
CLEAR Wisdom may fill a niche for patients who can’t get levels down.
Latest News
ACP recommends ways to address rising drug prices
One of the College’s suggestions is for the Medicare Part D low-income subsidy program to be modified.
Conference Coverage
Women undergoing hysterectomy, myomectomy have similar short-term outcomes
PHILADELPHIA – Patients had similar fibroid treatment benefits despite different baseline characteristics.
Feature
Drug spending driving up Part B premiums and deductibles
“These higher costs have a ripple effect and result in higher Part B premiums and deductibles.”
Feature
DACA lands before Supreme Court
Physician organizations argue that access to health care would be demeaned if DACA-affected doctors and trainees were forced to leave the United...
Latest News
Statins cut long-term CVD risk in kids with familial hypercholesterolemia
There were no cardiovascular-related deaths and one event in treated patients who were followed for 20 years.